Aligos Therapeutics Inc (ALGS)

15.19 -1.08  -6.64% NASDAQ Nov 29, 16:00 15.27 +0.08  +0.53% Pre-Market: 20:00 USD

Aligos Therapeutics Total Assets (Quarterly):

263.07M for Sept. 30, 2021
View 4,000+ financial data types
View Full Chart

Total Assets (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Total Assets (Quarterly) Data

View and export this data going back to 2019. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2021 263.07M
June 30, 2021 211.88M
March 31, 2021 234.54M
Dec. 31, 2020 265.30M
Sept. 30, 2020 92.18M
June 30, 2020 148.68M
Dec. 31, 2019 146.52M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Benchmarks

CEL-SCI Corp 79.64M
AIM ImmunoTech Inc 63.08M
NovaBay Pharmaceuticals Inc 12.24M

Total Assets (Quarterly) Range, Past 5 Years

Minimum 92.18M Sep 2020
Maximum 265.30M Dec 2020
Average 194.60M

Total Assets (Quarterly) Related Metrics

Total Liabilities (Quarterly) 46.06M
Shareholders Equity (Quarterly) 217.01M
Current Ratio 7.150





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.